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Abstract
Background: Pain is a common condition with a significant physical, psychosocial, and economic impact. Due to enormous
progress in mobile device technology as well as the increase in smartphone ownership in the general population, mobile apps can
be used to monitor patients with pain and support them in pain management.
Objective: The aim of this review was to assess the efficacy of smartphone or computer tablet apps in the management of
patients with pain.
Methods: In December 2017, a literature search was performed in the following databases: MEDLINE, EMBASE, CINAHL,
Cochrane, and PsycINFO. In addition, a bibliography search was conducted. We included studies with at least 20 participants
per arm that evaluated the effects of apps on smartphones or computer tablets on improvement in pain.
Results: A total of 15 studies with 1962 patients met the inclusion criteria. Of these, 4 studies examined the effect of mobile
apps on pain management in an in-clinic setting and 11 in an out-clinic setting. The majority of the original studies reported
beneficial effects of the use of a pain app. Severity of pain decreased in most studies where patients were using an app compared
with patients not using an app. Other outcomes, such as worst pain or quality of life showed improvements in patients using an
app. Due to heterogeneity between the original studies—patient characteristics, app content, and study setting—a synthesis of
the results by statistical methods was not performed.
Conclusions: Apps for pain management may be beneficial for patients, particularly in an out-clinic setting. Studies have shown
that pain apps are workable and well liked by patients and health care professionals. There is no doubt that in the near future,
mobile technologies will develop further. Medicine could profit from this development as indicated by our results, but there is a
need for more scientific inputs. It is desirable to know which elements of apps or additional devices and tools may improve
usability and help patients in pain management.
(JMIR Mhealth Uhealth 2018;6(10):e11231)   doi:10.2196/11231
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Introduction
Mobile device technology has improved enormously in the past
years. With higher screen resolution or better processor
performance, not only has the hardware improved but also many
software programs known as mobile apps have been developed,
thereby setting up a technological revolution. Use of internet
on smartphones and the proportion of total internet use have
increased within the past few years [1-3] and are part of the
daily life worldwide. The number of health-related mobile apps
increased rapidly within the past 10 years; in 2017, about 40%
of the more than 300,000 apps available on the market were
related to health issues, including monitoring and management
of illnesses [4]. Chronic illnesses seem to be a particular target
for the use of these apps. The result of a review showed that the
use of apps helps to improve asthma control and even lung
function. Patients’ symptoms and medication usage are recorded,
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and recommendations to adapt treatment, for example, to
increase the dose of inhaled drugs, are provided [5]. Patients
with type 1 diabetes appreciate an app as a supplement for
disease management (eg, communication with health care
professionals) [6]. The use of a smartphone app shortens times
for medical personnel to review glucose-level diaries from
patients [7] and has the potential for improving glucose control
in type 1 and 2 diabetes [7,8].
Pain, acute and chronic, is a substantial burden on individuals,
health care systems, and employers [9]. Patients with acute pain
need to be treated carefully to prevent abuse of pain medication,
in particular the abuse of opioids, and to prevent the
development of chronic pain. Apps assist to monitor patients
with acute or chronic pain and can inform and support them in
the management of pain, for example, changes in the dosage of
analgesics, early detection of adverse effects of analgesics, or
providing coping strategies to manage pain. Published
(systematic) reviews appraised the usability of smartphone or
computer tablet app use in patients with pain. The reviews show
that many of the commercially available apps lack usability and
have other limitations, such as absence of rigorous scientific
evaluation of the provided content and the recommendations
given to patients [10-17]. None of the published reviews
assessed the efficacy of apps in the management of patients
with acute or chronic pain. The objective of this review is to
assess the efficacy of smartphone or computer tablet apps in
the management of patients with pain.
Methods
Data Reporting
This systematic review is based on the preferred reporting items
for systematic reviews and meta-analyses (PRISMA) [18].
Literature Search
At the end of December 2017, a systematic literature search
was commissioned to the Careum Bibliothek of the University
of Zurich. The following electronic databases were searched by
an experienced librarian: MEDLINE, EMBASE, CINAHL,
Cochrane, and PsycINFO. We used, among others, the following
search terms as medical subject headings and other subject
headings: “Pain+,” “Pain Management,” “Pain Measurement,”
“Cellular Phone+,” “Mobile Devices,” “Mobile Applications,”
“Telehealth,” and “Telemedicine+.” Detailed description of one
search strategy is provided in Multimedia Appendix 1. Only
articles written in English or German were considered. No
restriction regarding publication date was applied.
Eligibility Criteria
Studies included in this review evaluated the effects of mobile
apps (which we refer to as apps and are defined as a type of
application software designed to run on a mobile device [19])
on smartphones or computer tablets on improvement in pain.
Studies with at least 20 participants per arm were included and
could have an in-clinic or an out-clinic setting. In-clinic setting
describes the situation when the intervention with an app was
made in a hospital, clinic, or another institution only, regardless
of whether patients were in ambulatory or stationary treatment
(being cared for at least 24 hours in a hospital). Out-clinic
describes the setting when the intervention with an app was
performed by the patients themselves in an ambulatory
treatment, meaning patients could use the app wherever they
were.
Studies were excluded if devices other than a smartphone or
computer tablet (eg, smartwatches, palmtops, handheld
computers, or similar devices) or if an app not defined as above
was used for data collection (eg, internet website and short
message service [SMS]). Furthermore, exclusion criteria were
the use of apps designed for diagnosis of a medical condition
or not explicitly designed for pain-level recording, management,
or treatment (eg, usual music players, video conference
programs, and video games). These exclusion criteria did not
apply if there was another app that was designed to take part in
the study, for example, pain diary. In addition, studies were
excluded if they included patients with a cognitive handicap,
did not provide sufficient baseline data, described the
development process of an app without measuring the effects
of app use on pain, were conducted in the field of veterinary
health, or were not available for purchase.
Study Selection and Data Extraction
All references were initially screened by title and abstract by 2
reviewers (SET and JMB) for relevance. Finally, full-text
analysis for eligibility was performed by SET and JMB
independently. Disagreements were discussed and resolved by
consensus or third-party arbitration (JS).
Outcomes
The primary outcome of interest of this systematic review was
improvement of pain. Other outcomes of interest assessed in
the studies, such as worst pain (the worst pain intensity during
a certain defined observational period) or improvement in
mobility were also included in analysis.
Quality of Studies
The checklist of the Scottish Intercollegiate Guidelines Network
(SIGN) [20] for randomized controlled trials (RCTs) was used
to review the quality of included RCTs. Overall assessment of
each study focused on bias minimization was rated in categories;
RCT categories are high quality (++), acceptable (+), low quality
(−), and reject (0). High ratings mean the majority of criteria
are met and further research is unlikely to change results;
acceptable quality is provided by studies in which most criteria
are met with few flaws, but conclusions may change after future
studies. Low quality is given if either most criteria are not met
or significant flaws in key aspects of the study design are
present, and therefore, further studies may change conclusions.
If a study did not meet the SIGN quality criteria and was
considered to be in the category unacceptable, it was rejected.
For before-after studies (often called pre-post studies where
variables are measured before and after an intervention and all
participants are assigned to 1 intervention group), no checklist
is required [20].
Statistics
The primary objective of this study was to assess the mean pain
difference between intervention and control groups or before
and after intervention. If data for several time points were
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available, the last one was considered to be the most relevant
to our analysis. Heterogeneity of studies did not allow
meta-analysis; so, only descriptive and comparative analysis
was used to summarize findings across all studies.
A secondary objective was to summarize other outcomes as
well as applicability and feasibility of the apps in a qualitative
way. Most of the additional outcomes reviewed were too
heterogeneous to compare statistically. Qualitative descriptive
exploration was performed, and the most important results were
summarized in a table.
For the primary comparative analysis, studies were included if
sufficient data were available and measurement scales were
comparable. Only study results with very similar pain rating
scales were included (eg, Visual Analog Scale, VAS, on a scale
of 0-10; numeric rating scale, NRS, 0-10; and VAS on a scale
of 0-100), and where necessary, different pain score scales were
rescaled to a 0- to 10-point scale. We graphically show the mean
pain scores over time separately for each study arm where
available. The effects of treatment in the multiple-arm studies
with sufficient data for comparison are shown in a forest plot.
Studies that did not have an observational period—all of which
have an in-clinic study setting—are shown in a separate graph.
If data were missing and could not be calculated from the other
available data, corresponding authors were contacted twice via
email. If authors did not respond, data were considered missing.
Results
Study Selection
As shown in Figure 1, systematic literature search retrieved
2232 studies, which were reduced to 1258 after deduplication.
After further manual deduplication, 1230 studies remained.
After an additional bibliography screening of the relevant
studies, 8 additional scientific studies were included, leading
to 1238 studies. After title and abstract screening, 1193 articles
were excluded. Finally, 45 full texts were reviewed closely
using inclusion and exclusion criteria as well as criteria for the
methodological quality, resulting in 15 eligible studies. The
main reasons for exclusion are displayed in Figure 1.
Study Overview
Characteristics of included studies are shown in Table 1 and in
Multimedia Appendix 2. A total of 7 RCTs [21-27], 6
before-after studies [28-33], 1 controlled before-after study [34],
and one retrospective data analysis [35] with a total of 1962
patients were reviewed. Of these, 11 studies were conducted in
an out-clinic setting and 4 studies in an in-clinic setting. In
addition, 8 of the studies were controlled (7 RCTs and 1
controlled before-after study); 1 was a 3-armed RCT. Moreover,
7 studies were single arm, 6 of which compared baseline to
follow-up parameters (before and after), and 1 was a
retrospective analysis of collected data [35]. Studies were
published between 2015 and early 2018. Publication date of
Blödt et al [21] differs from literature search because citation
recommendation is dated for 2018, whereas the article was
available online in 2017. The mean age of participants ranged
between 12 and 68 years, and the follow-up period ranged
between 0 and 28 days for in-clinic setting and 14 and 180 days
for out-clinic setting. A total of 15 studies were conducted using
a smartphone, 3 gave the possibility to use an app designed for
multiple devices (smartphone, computer tablet, and computer
[23,33,35]), and 2 studies were conducted solely with computer
tablets [26,34]. A total of 12 apps were used for treatment of
chronic pain; 2 interventions were used for management of
singular acute pain [26,28] and 1 for recurrent (menstrual) pain
[21]. Detailed information about each app used in the included
studies can be found in Multimedia Appendix 3.
Missing Data
One study did not report mean pain values but only mean change
in pain values. Therefore, description of results but no graphic
representation was possible [26]. Schatz et al [24] did not
compare baseline to follow-up mean pain values, and
consequently, the study could also not be included in the
graphical representation. Authors of studies with missing data
were contacted through email (corresponding email address on
publication), but none of them responded. Huber et al [35] did
not report the last day of use of the app in their intention-to-treat
(ITT) analysis. Therefore, graphical representation was not
possible for ITT analysis (missing x-axis value) but only for
patients who completed the full observational time of this
retrospective analysis.
Effects of Apps on Pain
Figure 2 shows improvement in pain over time, and Figure 3
illustrates the effect size of the intervention in 6 controlled
studies [21-23,25,27,34]. One study did not provide information
about the standard deviation, and therefore, only mean pain
values are shown in the graph [22]. In addition, 4 studies
reported a significant improvement in pain in the group using
the app [21,23,25,27]. In another study [21], patients showed
no significant improvement at follow-up after 29 and 58 days.
Skrepnik et al [25] reported only mean percentage change in
walking pain; therefore, significance of mean change in pain
was not possible to calculate. One study showed nonsignificant
tendency toward improvement [22]; 1 study did not report
improved pain in the intervention group [34].
Figure 4 shows a mean decrease in pain over time in 5
single-arm studies [30-33,35]. All studies showed a significant
decrease over time. Huber et al’s [35] ITT comparison of
baseline pain to mean pain at the end of the observational time
showed statistically significant decrease. Figure 5 shows a
decrease in pain in 2 single-arm studies, with immediate
postintervention measurements. One study showed a statistically
significant decrease in chronic pain; the other showed no
decrease in patients with acute pain [28,29]. Schatz et al [24]
did not report about the severity of pain at baseline and
follow-up. Therefore, we were not able to depict the results
graphically. However, analysis based on daily pain diary data
showed lower next-day pain in the intervention group compared
with control group. Stinley et al [26] did not provide mean pain
measurements; therefore, graphic depiction was also not
possible. They reported that pain scores between groups did not
differ.
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Figure 1. Study flow.
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Table 1. Baseline characteristics of all included studies.
Type of painFollow up
(days)
Age, mean (SD)Female, n (%)Patients, NDeviceStudy designAuthor, year
Recurrent menstrual pain174c24 (3.6)221 (100)221SbRCTaBlödt et al, 2018 [21]
Chronic cancer1467.5 (N/Ad)14 (30.4)46SRCTSun et al, 2017 [27]
Chronic walking pain9062.6 (9.4)106 (50.2)211SRCTSkrepnik et al, 2017 [25]
Chronic cancer2160.1 (12.7)103 (48.1)214TfcBASeRaj et al, 2017 [34]
Chronic cancer4259 (11)44 (52.4)84S/T/ChBASgOldenmenger et al, 2017 [33]
Chronic neck pain5628.1 (3)10 (43.5)23SBASLee et al, 2017 [32]
Chronic cancer2814.2 (1.7)17 (42.5)40SBASJibb et al, 2017 [31]
Chronic low back pain8433.9 (10.9)105 (58.3)180S/T/CRDAiHuber et al, 2017 [35]
Chronic pain18046.7 (12.9)58 (64.4)90SBASJamison et al, 2016 [30]
Chronic pain—j47.4 (16.5)42 (79.3)53SBASGuétin, de Diego et al, 2016 [29]
Acute pain before coro-
narography
—61.3 (11.6)17 (48.6)35SBASGuétin, Brun et al, 2016 [28]
Acute needle stick pain—12.3 (2.9)20 (50)40TRCTStinley et al, 2015 [26]
Chronic pain in sickle
cell disease
11213 (2.5)27 (58.7)46SRCTSchatz et al, 2015 [24]
Chronic low back pain112N/A (N/A)358 (60)597S/T/CRCTIrvine et al, 2015 [23]
Chronic non cancer pain2848.6 (11.6)51 (75)82SRCTGuillory et al, 2015 [22]
aRCT: randomized controlled trial.
bS: smartphone.
cDuration of six menstruation cycles with a mean of 29 days.
dN/A: not available.
ecBAS: controlled before-after study.
fT: computer tablet
gBAS: before-after study.
hC: computer.
iRDA: retrospective data analysis.
jNot applicable.
Effects of Apps on Other Outcomes and Information
About Feasibility
Blödt et al [21] reported that patients using the app had pain for
fewer days and needed less pain medication compared with the
control group. In 2 studies [21,33], worst pain improved using
the app but did not in another study [34]. Furthermore,
statistically significant decreases were found in momentary
pain, total pain interference (eg, general activity or mood), and
pain catastrophizing in 1 study [30]. Anxiety decreased in
patients using the app in 2 studies [28,29], whereas there was
no reduction in another study [30]. Stinley et al [26] reported
only a decrease in anxiety in the subgroup of patients with high
anxiety levels. Guillory et al [22] reported statistically significant
improvements in pain interference with general activities, pain
interference with sleep, pain interference in relation with others,
and positive affect for app users compared with the control
group during the intervention period. However, 1 week after
the intervention period, sleep pain and positive affect were not
significant any more. In another study, statistically significant
improvements in functionality, well-being, productivity, and
presenteeism at work were reported for the treatment group
compared with the control group [23]. One study found that
age, ethnicity, and gender did not influence compliance or
satisfaction with the app [30].
All studies evaluating changes in quality of life revealed a
statistically significant improvement in the groups using an app
[23,27,31,32]. In addition, 8 studies reported high satisfaction
with the ease of use of the app [21,23,25,27-29,33,36], and 3
studies stated good feasibility of app use with high diary
completion rates [22,27,31]. Further details about the additional
outcomes can be found in Multimedia Appendix 4.
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Figure 2. Improvement in pain over time in multiple armed studies. Pain scale (Numeric Rating Scale): 0-10.
Figure 3. Forest plot of intervention effect on pain in multiple armed studies. Pain scale (Numeric Rating Scale): 0-10.
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Figure 4. Decrease in pain in out-clinic before-after studies and in the retrospective data analysis. Pain scale (Numeric Rating Scale): 0-10.
Figure 5. Decrease in pain in in-clinic before-after studies. Pain scale (Numeric Rating Scale): 0-10.
Methodological Quality of the Randomized Controlled
Trials
Multimedia Appendix 5 shows the risks of biases of all included
RCTs using the corresponding SIGN checklist [20].
Furthermore, 1 RCT was of high quality [24], and 6 RCTs
[21-23,25-27] were of acceptable quality. The studies of
acceptable quality had a deficiency in at least one of the
following areas: description of random allocation (checklist
item 1.2), concealment (1.3), comparability at baseline (1.5),
missing ITT analysis (1.9), or missing multisite comparisons
(1.10).
Discussion
Principal Findings
The main objective of this review was to evaluate the efficacy
of apps on smartphones or tablets for the management of patients
with pain. The results of 7 RCTs, 6 before-after studies, 1
controlled before-after study, and 1 retrospective data analysis
were included in this review. The majority of the original studies
reported beneficial effects of the use of a pain app. Severity of
pain decreased in most studies in patients using an app compared
with those not using an app. Other outcomes, such as worst pain
or quality of life, showed improvements in patients using an
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app. Due to heterogeneity between the original studies—patient
characteristics, app content, and study setting—a synthesis of
the results by statistical methods was not performed.
Comparison With Existing Literature
To the best of our knowledge, this is the first systematic review
about the efficacy of smartphone or computer tablet apps for
the management of patients with pain. There are published
systematic reviews that study the quality of the content (eg,
evidence-based interventions or inclusion of health care
professionals in the development process) and ease of use of
commercially available apps for pain management [10-15,17].
None of the reviews that were reported assessed the overall
effectiveness of apps as tools for managing pain in patients.
Authors of 3 reviews [10-12] criticized that the apps were not
comprehensive in terms of pain self-management and that health
care professionals and patients were scarcely involved in the
development of the app. Furthermore, they reported a lack of
scientific evidence in app content. Machado et al [13] examined
the quality of apps for low back pain. Although 58 out of 61
apps included some type of intervention (eg, information for
strengthening and/or stretching exercises and yoga, which was
listed in the National Institute for Health and Care Excellence
guidelines for low back pain [37]), most of the assessed apps
lacked evidence and were of poor quality. Bhattarai et al [14]
evaluated smartphone apps for self-management in patients with
arthritic pain in their systematic review. Out of 373 assessed
apps, only 4 met the authors’ inclusion criteria, and 3 of them
did not fulfill the minimal usability criteria. Portelli and Eldred
[15] reviewed the degree to which apps adhere to evidence-based
practices in psychological research for pain management.
Integrated theoretical reference to cognitive behavioral therapy
(CBT) principles was only present in 6 out of 195 apps
investigated.
Other studies not meeting our inclusion criteria (eg, use of other
devices or use of apps not specifically made for intervention)
showed results similar to the studies included in our analysis.
In the study of Kristjánsdóttir et al [38], patients used early
smartphone models to fill in pain diaries on the internet and to
communicate with the therapist through SMS in a 4-week
intervention trial. As a result, catastrophizing of pain was
reduced in the intervention compared with the control group
after 4 weeks and 5 months, but benefits were no longer evident
after an 11-month follow-up assessment [39]. Somers et al [40]
demonstrated that remote pain-coping skills training delivered
via videoconferencing on a computer tablet is feasible and
effective in decreasing pain, reducing psychological distress,
and pain catastrophizing. Basch et al [41] demonstrated that
access to a Web-based collection of information about symptoms
at home during chemotherapy with alerts to treating staff is
beneficial for patients. The intervention group had better quality
of life, less emergency room admissions, and longer
chemotherapy than the control group.
Reviews about the effects of apps in other medical fields showed
reduction in anxiety [42] and depressive symptoms [43] as well
as improvement in asthma control and lung function [5]. Another
study reported the use of a medication app, which improved
medication adherence and lowered the rate or number of missed
medications [44]. In patients with diabetes, apps shortened times
for clinical personnel to review glucose diaries compared with
the traditional personal glucose diaries [7] and have the potential
of improving glucose control in type 1 and 2 diabetes [7,8], as
well as increasing adherence to treatment in patients older than
60 years [45]. Another app was effective in promoting physical
activity measured as steps per day after 8 weeks [46].
One study reported no improvement in systolic blood pressure
with app use, although there was a small improvement in
medication adherence [47]. Hurkmans et al [48] showed that
addition of an app in a weight loss program did not improve
dietary patterns or physical activity.
Comment on Results
For the sake of overview, we depicted acute and chronic pain
outcome studies in the same figures. However, acute pain and
chronic pain are two different entities; therefore, direct
comparison is difficult, and this should be considered when
interpreting the results. Furthermore, part of our results showing
no effect of app use on pain management can be explained. The
app examined by Raj et al [34] was a clinical decision support
tool for physicians treating patients with cancer pain to evaluate
improvement in pain control and to suggest treatment changes
in opioid prescription (developed by mathematical algorithms).
However, physicians were free to use or ignore the treatment
suggestions provided by the app. Effectively, there was no
statistically significant difference in either new prescription of
or change in opioid medication in the intervention group
compared with the control group. Guétin et al [28] did not report
a decrease in pain during coronarography, which is not
surprising because of the absence of pain in most patients before
the procedure. Stinley et al [26] investigated pain and anxiety
during venepuncture in children. The intervention group
generated a mandala (defined by the authors as a drawing in
which artists create a design using a circular outline [26]) on a
computer tablet, and the control group received standard care
treatment. The absolute pain levels were not reported; therefore,
understanding why the intervention did not improve pain is
difficult.
Limitations and Strengths
The main limitation of our review is the heterogeneity of the
included studies for the synthesis of study results. On the other
hand, this enables existing data to be represented in general
without selection bias. Furthermore, apps are a new element in
telehealth and their development is still progressing. Indeed,
apps were only made available for a wide population in 2008
and 2009, when the Apple’s App store and Google Play for
Android, respectively, were introduced. Our strength is that this
review is based on the PRISMA guidelines [18] and that the
SIGN checklists [20] were used to critically appraise the
included studies. The heterogeneity between the studies
regarding the eligibility criteria, interventions, apps, and
outcome selection prevented a meta-analysis. We attempted to
compensate for this limitation by supplying a well-balanced,
detailed, and qualitative review of the studies included.
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Implications
In the management of patients with pain, apps can provide
patients a wide range of features such as pain diary, educational
features, reminders, treatment recommendation aspects, and
direct communication with health care personnel in a single
mobile app. Furthermore, intelligent systems such as chatbots
or virtual assistants are already part of daily life for many people.
These new technologies should be introduced into telehealth in
the near future, and their testing for validity and usability is
crucial. Correspondingly, there is a need for more high-quality
studies for the evaluation of the efficacy of these new
instruments.
Furthermore, our review showed that a standardized assessment
of pain is lacking in the included studies, and therefore, it would
be desirable that the scientific community agrees on a
standardized protocol for pain assessment. In addition, there is
a need for detailed reporting of the structure, data assessment,
and functions of the apps and studies to investigate the elements
of the apps or additional devices or tools that may improve
usability and help patients in pain management. This information
would strengthen future studies and allow researchers to
synthesize the results of different studies.
Conclusions
Apps for pain management may be beneficial for patients,
particularly in an out-clinic setting. Studies have shown that
pain apps are workable and well liked by patients and health
care professionals. There is no doubt that in the near future,
mobile technologies will develop further. Medicine could profit
from this development as our results indicate, but there is a need
for more scientific inputs. It is desirable to know which elements
of apps or additional devices or tools may improve usability
and help patients in pain management.
 
Acknowledgments
The authors wish to thank the Helmut Horten Foundation for supporting this study financially and also Dr Martina Gosteli,
University of Zurich, for conducting the literature search.
Authors' Contributions
SET was involved in the study conception, selection of trials, data extraction, data analysis, interpretation of results, and drafting
of the manuscript and its revision. IG was involved in the data extraction, data analysis, and graphical presentation. GP was
involved in graphical presentation and drafting of the manuscript. JS was involved in the study conception, data analysis,
interpretation of results, and drafting of the manuscript and revision. JMB was involved in the study conception, selection of
trials, data extraction, data analysis, interpretation of results, and drafting of the manuscript and its revision.
Conflicts of Interest
None declared.
Multimedia Appendix 1
Search strategy for Ovid MEDLINE(R).
[PDF File (Adobe PDF File), 71KB - mhealth_v6i10e11231_app1.pdf ]
Multimedia Appendix 2
Baseline characteristics of all included studies.
[PDF File (Adobe PDF File), 32KB - mhealth_v6i10e11231_app2.pdf ]
Multimedia Appendix 3
Detailed information of apps used in the included studies.
[PDF File (Adobe PDF File), 115KB - mhealth_v6i10e11231_app3.pdf ]
Multimedia Appendix 4
Additional outcomes of interest.
[PDF File (Adobe PDF File), 117KB - mhealth_v6i10e11231_app4.pdf ]
Multimedia Appendix 5
Scottish Intercollegiate Guidelines Network (SIGN) checklist for randomized controlled trials.
[PDF File (Adobe PDF File), 22KB - mhealth_v6i10e11231_app5.pdf ]
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 10 | e11231 | p.9http://mhealth.jmir.org/2018/10/e11231/
(page number not for citation purposes)
Thurnheer et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
References
1. Eurostat. Digital economy and society statistics - households and individuals 2016 URL: http://ec.europa.eu/eurostat/
statistics-explained/index.php/Digital_economy_and_society_statistics_-_households_and_individuals [WebCite Cache
ID 6zm89wTlo]
2. Eurostat. Mobile connection to internet 2016 URL: http://ec.europa.eu/eurostat/statistics-explained/index.php/
Mobile_connection_to_internet [WebCite Cache ID 6zm8WwFMG]
3. Eurostat. 2016. Internet use by individuals URL: http://ec.europa.eu/eurostat/documents/2995521/7771139/
9-20122016-BP-EN.pdf/f023d81a-dce2-4959-93e3-8cc7082b6edd [WebCite Cache ID 6zm8bZuAV]
4. Business Insider. IQVIA Institute for Human Data Science Study: Impact of Digital Health Grows as Innovation, Evidence
and Adoption of Mobile Health Apps Accelerate 2017 URL: https://tinyurl.com/y7qamjat [WebCite Cache ID 6zm9E9rhv]
5. Farzandipour M, Nabovati E, Sharif R, Arani MH, Anvari S. Patient self-management of asthma using mobile health
applications: a systematic review of the functionalities and effects. Appl Clin Inform 2017 Dec;8(4):1068-1081. [doi:
10.4338/ACI-2017-07-R-0116] [Medline: 29241254]
6. Husted GR, Weis J, Teilmann G, Castensøe-Seidenfaden P. Exploring the influence of a smartphone app (Young with
Diabetes) on young people's self-management: qualitative study. JMIR Mhealth Uhealth 2018 Feb 28;6(2):e43 [FREE Full
text] [doi: 10.2196/mhealth.8876] [Medline: 29490897]
7. Ryan EA, Holland J, Stroulia E, Bazelli B, Babwik SA, Li H, et al. Improved A1C levels in type 1 diabetes with smartphone
app use. Can J Diabetes 2017 Feb;41(1):33-40. [doi: 10.1016/j.jcjd.2016.06.001] [Medline: 27570203]
8. Cui MX, Wu XY, Mao JF, Wang X, Nie M. T2DM self-management via smartphone applications: a systematic review and
meta-analysis. PLoS One 2016;11(11):e0166718 [FREE Full text] [doi: 10.1371/journal.pone.0166718] [Medline: 27861583]
9. Breivik H, Eisenberg E, O'Brien T, OPENMinds. The individual and societal burden of chronic pain in Europe: the case
for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health 2013
Dec 24;13:1229 [FREE Full text] [doi: 10.1186/1471-2458-13-1229] [Medline: 24365383]
10. Lalloo C, Jibb LA, Rivera J, Agarwal A, Stinson JN. "There's a Pain App for That": review of patient-targeted smartphone
applications for pain management. Clin J Pain 2015 Jun;31(6):557-563. [doi: 10.1097/AJP.0000000000000171] [Medline:
25370138]
11. Lalloo C, Shah U, Birnie KA, Davies-Chalmers C, Rivera J, Stinson J, et al. Commercially available smartphone apps to
support postoperative pain self-management: scoping review. JMIR Mhealth Uhealth 2017 Oct 23;5(10):e162 [FREE Full
text] [doi: 10.2196/mhealth.8230] [Medline: 29061558]
12. Rosser BA, Eccleston C. Smartphone applications for pain management. J Telemed Telecare 2011;17(6):308-312. [doi:
10.1258/jtt.2011.101102] [Medline: 21844177]
13. Machado GC, Pinheiro MB, Lee H, Ahmed OH, Hendrick P, Williams C, et al. Smartphone apps for the self-management
of low back pain: a systematic review. Best Pract Res Clin Rheumatol 2016 Dec;30(6):1098-1109. [doi:
10.1016/j.berh.2017.04.002] [Medline: 29103552]
14. Bhattarai P, Newton-John T, Phillips JL. Quality and usability of arthritic pain self-management apps for older adults: a
systematic review. Pain Med 2018 Mar 01;19(3):471-484. [doi: 10.1093/pm/pnx090] [Medline: 28541464]
15. Portelli P, Eldred C. A quality review of smartphone applications for the management of pain. Br J Pain 2016
Aug;10(3):135-140 [FREE Full text] [doi: 10.1177/2049463716638700] [Medline: 27583140]
16. Wallace LS, Dhingra LK. A systematic review of smartphone applications for chronic pain available for download in the
United States. J Opioid Manag 2014 Feb;10(1):63-68. [doi: 10.5055/jom.2014.0193] [Medline: 24604571]
17. Reynoldson C, Stones C, Allsop M, Gardner P, Bennett MI, Closs SJ, et al. Assessing the quality and usability of smartphone
apps for pain self-management. Pain Med 2014 Jun;15(6):898-909. [doi: 10.1111/pme.12327] [Medline: 24422990]
18. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. PLoS Med 2009 Jul 21;6(7):e1000097-e1000093 [FREE Full text] [doi:
10.1371/journal.pmed.1000097] [Medline: 19621072]
19. Techopedia. Mobile Application (Mobile App) URL: https://www.techopedia.com/definition/2953/
mobile-application-mobile-app [WebCite Cache ID 6zm9S3yON]
20. Scottish Intercollegiate Guidelines Network. Critical appraisal notes and checklists URL: http://www.sign.ac.uk/
checklists-and-notes.html [WebCite Cache ID 6zm9lFML1]
21. Blödt S, Pach D, Eisenhart-Rothe SV, Lotz F, Roll S, Icke K, et al. Effectiveness of app-based self-acupressure for women
with menstrual pain compared to usual care: a randomized pragmatic trial. Am J Obstet Gynecol 2018
Feb;218(2):227.e1-227.e9 [FREE Full text] [doi: 10.1016/j.ajog.2017.11.570] [Medline: 29155036]
22. Guillory J, Chang P, Henderson CR, Shengelia R, Lama S, Warmington M, et al. Piloting a text message-based social
support intervention for patients with chronic pain: establishing feasibility and preliminary efficacy. Clin J Pain 2015
Jun;31(6):548-556 [FREE Full text] [doi: 10.1097/AJP.0000000000000193] [Medline: 25565587]
23. Irvine AB, Russell H, Manocchia M, Mino DE, Cox GT, Morgan R, et al. Mobile-web app to self-manage low back pain:
randomized controlled trial. J Med Internet Res 2015 Jan 02;17(1):e1 [FREE Full text] [doi: 10.2196/jmir.3130] [Medline:
25565416]
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 10 | e11231 | p.10http://mhealth.jmir.org/2018/10/e11231/
(page number not for citation purposes)
Thurnheer et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
24. Schatz J, Schlenz AM, McClellan CB, Puffer ES, Hardy S, Pfeiffer M, et al. Changes in coping, pain, and activity after
cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones. Clin J Pain
2015 Jun;31(6):536-547 [FREE Full text] [doi: 10.1097/AJP.0000000000000183] [Medline: 25503599]
25. Skrepnik N, Spitzer A, Altman R, Hoekstra J, Stewart J, Toselli R. Assessing the impact of a novel smartphone application
compared with standard follow-up on mobility of patients with knee osteoarthritis following treatment with Hylan G-F 20:
a randomized controlled trial. JMIR Mhealth Uhealth 2017 May 09;5(5):e64 [FREE Full text] [doi: 10.2196/mhealth.7179]
[Medline: 28487266]
26. Stinley NE, Norris D, Hinds PS. Creating mandalas for the management of acute pain symptoms in pediatric patients. Art
Ther (Alex) 2015 Jun 22;32(2):46-53. [doi: 10.1080/07421656.2015.1028871]
27. Sun Y, Jiang F, Gu JJ, Wang YK, Hua H, Li J, et al. Development and testing of an Intelligent Pain Management System
(IPMS) on mobile phones through a randomized trial among Chinese cancer patients: a new approach in cancer pain
management. JMIR Mhealth Uhealth 2017 Jul 25;5(7):e108 [FREE Full text] [doi: 10.2196/mhealth.7178] [Medline:
28743681]
28. Guétin S, Brun L, Deniaud M, Clerc J, Thayer JF, Koenig J. Smartphone-based music listening to reduce pain and anxiety
before coronarography: a focus on sex differences. Altern Ther Health Med 2016 Jul;22(4):60-63. [Medline: 27548494]
29. Guétin S, Diego E, Mohy F, Adolphe C, Hoareau G, Touchon J, et al. A patient-controlled, smartphone-based music
intervention to reduce pain: A multi-center observational study of patients with chronic pain. Eur J Integr Med 2016
Jun;8(3):182-187. [doi: 10.1016/j.eujim.2016.01.002]
30. Jamison RN, Mei A, Ross EL. Longitudinal trial of a smartphone pain application for chronic pain patients: predictors of
compliance and satisfaction. J Telemed Telecare 2018 Feb;24(2):93-100. [doi: 10.1177/1357633X16679049] [Medline:
27831496]
31. Jibb LA, Stevens BJ, Nathan PC, Seto E, Cafazzo JA, Johnston DL, et al. Implementation and preliminary effectiveness
of a real-time pain management smartphone app for adolescents with cancer: a multicenter pilot clinical study. Pediatr
Blood Cancer 2017 Oct;64(10). [doi: 10.1002/pbc.26554] [Medline: 28423223]
32. Lee M, Lee SH, Kim T, Yoo HJ, Kim SH, Suh DW, et al. Feasibility of a smartphone-based exercise program for office
workers with neck pain: an individualized approach using a self-classification algorithm. Arch Phys Med Rehabil 2017
Dec;98(1):80-87. [doi: 10.1016/j.apmr.2016.09.002] [Medline: 27693421]
33. Oldenmenger WH, Baan MA, van der Rijt CC. Development and feasibility of a web application to monitor patients'
cancer-related pain. Support Care Cancer 2018 Feb;26(2):635-642 [FREE Full text] [doi: 10.1007/s00520-017-3877-3]
[Medline: 28929433]
34. Raj SX, Brunelli C, Klepstad P, Kaasa S. COMBAT study - Computer based assessment and treatment - A clinical trial
evaluating impact of a computerized clinical decision support tool on pain in cancer patients. Scand J Pain 2017 Oct;17:99-106.
[doi: 10.1016/j.sjpain.2017.07.016] [Medline: 28850380]
35. Huber S, Priebe JA, Baumann KM, Plidschun A, Schiessl C, Tölle TR. Treatment of low back pain with a digital
multidisciplinary pain treatment app: short-term results. JMIR Rehabil Assist Technol 2017 Dec 04;4(2):e11 [FREE Full
text] [doi: 10.2196/rehab.9032] [Medline: 29203460]
36. Jamison RN, Jurcik DC, Edwards RR, Huang C, Ross EL. A pilot comparison of a smartphone app with or without 2-way
messaging among chronic pain patients: who benefits from a pain app? Clin J Pain 2017 Aug;33(8):676-686 [FREE Full
text] [doi: 10.1097/AJP.0000000000000455] [Medline: 27898460]
37. NICE. National Institute for Health and Care Excellence - Low back pain and sciatica in over 16s: assessment and management
2016 URL: https://www.nice.org.uk/guidance/ng59 [WebCite Cache ID 6zmA94XFX]
38. Kristjánsdóttir OB, Fors EA, Eide E, Finset A, Stensrud TL, van Dulmen S, et al. A smartphone-based intervention with
diaries and therapist-feedback to reduce catastrophizing and increase functioning in women with chronic widespread pain:
randomized controlled trial. J Med Internet Res 2013 Jan 07;15(1):e5-62 [FREE Full text] [doi: 10.2196/jmir.2249] [Medline:
23291270]
39. Kristjánsdóttir OB, Fors EA, Eide E, Finset A, Stensrud TL, van Dulmen S, et al. A smartphone-based intervention with
diaries and therapist feedback to reduce catastrophizing and increase functioning in women with chronic widespread pain.
part 2: 11-month follow-up results of a randomized trial. J Med Internet Res 2013 Mar 28;15(3):e72-e77 [FREE Full text]
[doi: 10.2196/jmir.2442] [Medline: 23538392]
40. Somers TJ, Abernethy AP, Edmond SN, Kelleher SA, Wren AA, Samsa GP, et al. A pilot study of a mobile health pain
coping skills training protocol for patients with persistent cancer pain. J Pain Symptom Manage 2015 Oct;50(4):553-558
[FREE Full text] [doi: 10.1016/j.jpainsymman.2015.04.013] [Medline: 26025279]
41. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes
during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016 Feb 20;34(6):557-565 [FREE Full text]
[doi: 10.1200/JCO.2015.63.0830] [Medline: 26644527]
42. Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J. Can smartphone mental health interventions reduce symptoms
of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord 2017 Dec 15;218:15-22 [FREE Full text] [doi:
10.1016/j.jad.2017.04.046] [Medline: 28456072]
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 10 | e11231 | p.11http://mhealth.jmir.org/2018/10/e11231/
(page number not for citation purposes)
Thurnheer et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
43. Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health
interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017
Oct;16(3):287-298 [FREE Full text] [doi: 10.1002/wps.20472] [Medline: 28941113]
44. Mira JJ, Navarro I, Botella F, Borrás F, Nuño-Solinís R, Orozco D, et al. A Spanish pillbox app for elderly patients taking
multiple medications: randomized controlled trial. J Med Internet Res 2014 Apr 04;16(4):e99 [FREE Full text] [doi:
10.2196/jmir.3269] [Medline: 24705022]
45. Steinert A, Haesner M, Steinhagen-Thiessen E. [App-based self-monitoring in type 2 diabetes]. Z Gerontol Geriatr 2017
Aug;50(6):516-523. [doi: 10.1007/s00391-016-1082-5] [Medline: 27282168]
46. Glynn LG, Hayes PS, Casey M, Glynn F, Alvarez-Iglesias A, Newell J, et al. Effectiveness of a smartphone application to
promote physical activity in primary care: the SMART MOVE randomised controlled trial. Br J Gen Pract 2014
Jul;64(624):e384-e391 [FREE Full text] [doi: 10.3399/bjgp14X680461] [Medline: 24982490]
47. Morawski K, Ghazinouri R, Krumme A, Lauffenburger JC, Lu Z, Durfee E, et al. Association of a smartphone application
with medication adherence and blood pressure control: the MedISAFE-BP randomized clinical trial. J Am Med Assoc
Intern Med 2018 Jun 01;178(6):802-809. [doi: 10.1001/jamainternmed.2018.0447] [Medline: 29710289]
48. Hurkmans E, Matthys C, Bogaerts A, Scheys L, Devloo K, Seghers J. Face-to-face versus mobile versus blended weight
loss program: randomized clinical trial. JMIR Mhealth Uhealth 2018 Jan 11;6(1):e14 [FREE Full text] [doi:
10.2196/mhealth.7713] [Medline: 29326093]
Abbreviations
ITT: intention-to-treat
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
NRS: Numeric Rating Scale
RCT: randomized controlled trial
SIGN: Scottish Intercollegiate Guidelines Network
SMS: short message service
VAS: Visual Analog Scale
Edited by G Eysenbach; submitted 05.06.18; peer-reviewed by B Chaudhry, N Khalili-Mahani, R Lee; comments to author 19.07.18;
revised version received 06.08.18; accepted 08.08.18; published 22.10.18
Please cite as:
Thurnheer SE, Gravestock I, Pichierri G, Steurer J, Burgstaller JM
Benefits of Mobile Apps in Pain Management: Systematic Review
JMIR Mhealth Uhealth 2018;6(10):e11231
URL: http://mhealth.jmir.org/2018/10/e11231/ 
doi:10.2196/11231
PMID:30348633
©Simon E Thurnheer, Isaac Gravestock, Giuseppe Pichierri, Johann Steurer, Jakob M Burgstaller. Originally published in JMIR
Mhealth and Uhealth (http://mhealth.jmir.org), 22.10.2018. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The
complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and
license information must be included.
JMIR Mhealth Uhealth 2018 | vol. 6 | iss. 10 | e11231 | p.12http://mhealth.jmir.org/2018/10/e11231/
(page number not for citation purposes)
Thurnheer et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
